Security key
098070501
- Type / Class
- Equity / COM NEW
- Total 13F shares
- 57,427
- Share change
- +15,573
- Total reported value
- $69,689
- Price per share
- $1.22
- Number of holders
- 5
- Value change
- -$15,047
- Number of buys
- 5
- Number of sells
- 2
Report period
Q2 2024
Institutions
5
Top holders
5
BBLG full security history
Newer quarter: Q3 2024
Previous quarter: Q1 2024
Bone Biologics Corp SEC filings
Bone Biologics Corp company facts
Broader feeds
Reporting periods
Holder history for CUSIP 098070501
Recent filing periods:
Top shareholders of BBLG - Bone Biologics Corp - COM NEW (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Don Hankey |
3/4/5
|
Chairman of the Board, Director, 10%+ Owner |
—
mixed-class rows
|
7,144,395
mixed-class rows
|
$4,289,289 | — | 27 Mar 2023 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
—
class O/S missing
|
33,037
|
$568,236 | — | 31 Mar 2024 | |
| ARMISTICE CAPITAL, LLC |
13F
|
Company |
—
class O/S missing
|
37,000
|
$78,810 | — | 31 Mar 2024 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
—
class O/S missing
|
4,250
|
$9,052 | — | 31 Mar 2024 | |
| CLEAR STREET LLC |
13F
|
Company |
—
class O/S missing
|
100
|
$1,720 | — | 31 Mar 2024 | |
| UBS Group AG |
13F
|
Company |
—
class O/S missing
|
600
|
$1,278 | — | 31 Mar 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
—
class O/S missing
|
100
|
$414 | — | 31 Mar 2024 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
—
class O/S missing
|
4
|
$9 | — | 31 Mar 2024 | |
| Erick Lucera |
3/4/5
|
Director |
—
class O/S missing
|
85,763
|
— | — | 18 Sep 2023 |
Institutional Holders of Bone Biologics Corp - COM NEW (BBLG) as of Q2 2024
As of 30 Jun 2024,
Bone Biologics Corp - COM NEW (BBLG) was held by
5 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
57,427 shares.
The largest 5 holders included
UBS Group AG, HRT FINANCIAL LP, Tower Research Capital LLC (TRC), MFA WEALTH ADVISORS, LLC, and BANK OF AMERICA CORP /DE/.
This page lists
5
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
4
Q2 2024 holders
5
Holder diff
1
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.